EP2203478
Samsetningar og aðferðir til að nota mótefni gegn sklerostíni
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
10.10.2008EP published:
20.11.2013EP application number:
08838428.4
EP translation filed:
27.1.2014Grant published:
15.2.2014EPO information:
European Patent Register
Max expiry date:
9.10.2028Expiry date:
9.10.2026Next due date:
31.10.2026
Title:
COMPOSITIONS AND METHODS FOR USE OF ANTIBODIES AGAINST SCLEROSTIN
Timeline
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
KNEISSEL, MichaelaAddress:
Basel, CH
Name:
HALLEUX, ChristineAddress:
Dornach, CH
Name:
HU, Shou-IhAddress:
New ProvidenceNew Jersey, US
Name:
DIEFENBACH-STREIBER, BeateAddress:
Windach, DE
Name:
PRASSLER, JosefAddress:
Germering, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
07118414Date:
12.10.2007Country:
EP
Number:
08151911Date:
25.2.2008Country:
EP
Number:
08161342Date:
29.7.2008Country:
EP
Classification
Categories:
A61K 39/395, A61K 45/06, A61K 31/663, C07K 16/18, G01N 33/68
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 9.9.2014
Expires: 9.10.2015
Payer: Árnason Faktor
Number: 8
Paid: 10.9.2015
Expires: 9.10.2016
Payer: Árnason Faktor
Number: 9
Paid: 6.9.2016
Expires: 9.10.2017
Payer: Árnason Faktor
Number: 10
Paid: 11.9.2017
Expires: 9.10.2018
Payer: Árnason Faktor
Number: 11
Paid: 6.9.2018
Expires: 9.10.2019
Payer: Árnason Faktor
Number: 12
Paid: 9.9.2019
Expires: 9.10.2020
Payer: Árnason Faktor
Number: 13
Paid: 9.9.2020
Expires: 9.10.2021
Payer: Árnason Faktor ehf.
Number: 14
Paid: 7.9.2021
Expires: 9.10.2022
Payer: Árnason Faktor ehf.
Number: 15
Paid: 7.9.2022
Expires: 9.10.2023
Payer: Árnason Faktor ehf.
Number: 16
Paid: 25.9.2023
Expires: 9.10.2024
Payer: Árnason Faktor ehf.
Number: 17
Paid: 17.9.2024
Expires: 9.10.2025
Payer: Árnason Faktor ehf.
Number: 18
Paid: 2.10.2025
Expires: 9.10.2026
Payer: Árnason Faktor ehf.